Activation of GSK‐3 disrupts cholinergic homoeostasis in nucleus basalis of Meynert and frontal cortex of rats

The cholinergic impairment is an early marker in Alzheimer's disease (AD), while the mechanisms are not fully understood. We investigated here the effects of glycogen synthase kinse‐3 (GSK‐3) activation on the cholinergic homoeostasis in nucleus basalis of Meynert (NBM) and frontal cortex, the...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Cell Mol Med
Prif Awduron: Wang, Yue, Tian, Qing, Liu, En‐Jie, Zhao, Li, Song, Jie, Liu, Xin‐An, Ren, Qing‐Guo, Jiang, Xia, Zeng, Juan, Yang, Yu‐Tao, Wang, Jian‐Zhi
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: John Wiley and Sons Inc. 2017
Pynciau:
Original Articles
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5706587/
https://ncbi.nlm.nih.gov/pubmed/28656644
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.13262
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg